UK puts £80m behind dementia diagnosis push
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Newsletters and Deep Dive digital magazine
The UK is putting £80 million ($105 million) in funding behind nine technologies that it hopes will be able to diagnose dementia more quickly.
Industry must build custom solutions that leverage a pharmaceutical business’ unique assets – including its people.
An AI system can be cheap to buy and expensive to stop.
The infiltration of Australia's Medicare by an AI agent raises serious questions about patient privacy and the security of confidential pharma data.
Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.
Editor's Picks
Newsletters and Deep Dive
digital magazine